Freenome

Decision/Risk Analysis · Brisbane, CA · Founded 2014 · Privately Held (backing)

Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. Freenome is based in Brisbane, CA and was founded in 2014. It is valued at about $2.2 billion as of Oct 2026, set by institutional fund marks. It has raised $1.4 billion across 3 recorded rounds; the latest was a $240 million pipe round in Dec 2025.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
—
Total raised
$1.4B
Last round
PIPE
Dec 2025

Who backs Freenome?

53 investors
InvestorType
Andreessen HorowitzVenture capital
RA Capital ManagementAsset manager
GVVenture capital
Founders FundVenture capital
DCVCVenture capital
Realm Capital VenturesVenture capital
CRVVenture capital
AME Cloud VenturesVenture capital
Microsoft—
Innovation EndeavorsVenture capital
+ 43 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Freenome investors

53 investors are on record for Freenome, including Andreessen Horowitz, RA Capital Management, GV and Founders Fund. By type, the record holds 18 venture capital firms, 7 hedge funds and 2 asset managers. The pipe round in Dec 2025 drew 4 investors.

Free account
More of Freenome with a free account
  • ·The complete investor list: 53 names
  • ·Watch Freenome: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 53 firms already write checks for companies like Freenome in decision/risk analysis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View